Pharmacological treatment of HIV-associated pulmonary hypertension

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)CLINICAL PERSPECTIVE

(2015) Ioana R. Preston et al.   CIRCULATION

Human Immunodeficiency Virus-Associated Pulmonary Arterial Hypertension: Considerations for Pulmonary Vascular Diseases in the Developing World

(2015) G. Butrous   CIRCULATION

PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary hypertension in HIV infection: a prospective echocardiographic study

(2015) C Schwarze-Zander et al.   HIV MEDICINE

Efficacy of sildenafil in HIV-related pulmonary arterial hypertension

(2015) Valeria Pergola et al.   Journal of Cardiovascular Medicine

Management of Pulmonary Arterial Hypertension

(2015) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Macitentan on Hospitalizations

(2015) Richard N. Channick et al.   JACC-Heart Failure

Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension

(2014) Andrea Frustaci et al.   AIDS

Relationship between endothelin-1 levels and pulmonary arterial hypertension in HIV-infected patients

(2014) Maribel Q. Feijoo et al.   AIDS

Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection

(2014) Rushi V. Parikh et al.   AIDS

An Official American Thoracic Society Statement: Pulmonary Hypertension Phenotypes

(2014) Raed A. Dweik et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Noninfectious Pulmonary Complications of Human Immunodeficiency Virus Infection

(2014) Bashar Staitieh et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

CCR5 as a Treatment Target in Pulmonary Arterial Hypertension

(2014) Valérie Amsellem et al.   CIRCULATION

Echocardiographic screening for pulmonary arterial hypertension in HIV-positive patients

(2014) H. ten Freyhaus et al.   INFECTION

HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART Era

(2014) Gerald S. Bloomfield et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Ambrisentan therapy in pulmonary hypertension: clinical use and tolerability in a referral centre

(2014) Robin Condliffe et al.   Therapeutic Advances in Respiratory Disease

Human Immunodeficiency Virus-1 Transgene Expression Increases Pulmonary Vascular Resistance and Exacerbates Hypoxia-Induced Pulmonary Hypertension Development

(2014) Kristi M. Porter et al.   Pulmonary Circulation

Anticoagulation and Survival in Pulmonary Arterial Hypertension

(2013) Karen M. Olsson et al.   CIRCULATION

Updated Clinical Classification of Pulmonary Hypertension

(2013) Gerald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

(2013) Tomás Pulido et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension

(2013) G. Ruiter et al.   RHEUMATOLOGY

HIV Infection and the Risk of Acute Myocardial Infarction

(2013) Matthew S. Freiberg et al.   JAMA Internal Medicine

Schistosomiasis Causes Remodeling of Pulmonary Vessels in the Lung in a Heterogeneous Localized Manner: Detailed Study

(2013) Ewa Kolosionek et al.   Pulmonary Circulation

Enhanced Pulmonary Arteriopathy in Simian Immunodeficiency Virus–infected Macaques Exposed to Morphine

(2012) Leslie Spikes et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A prospective evaluation of pulmonary, systemic and hepatic hemodynamics in HIV-HCV coinfected patients prior and after antiviral therapy with pegylated interferon and ribavirin

(2012) Thomas Reiberger et al.   ANTIVIRAL THERAPY

Sildenafil Plasma Concentrations in Two HIV Patients with Pulmonary Hypertension Treated with Ritonavir-Boosted Protease Inhibitors

(2012) Pierangelo Chinello et al.   CURRENT HIV RESEARCH

Beta-adrenergic adaptation in idiopathic dilated cardiomyopathy: differences between children and adults

(2012) S. E. Lipshultz et al.   EUROPEAN HEART JOURNAL

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

(2012) Gérald Simonneau et al.   EUROPEAN RESPIRATORY JOURNAL

Curing HIV-associated pulmonary arterial hypertension: Figure 1–

(2012) C. Tcherakian et al.   EUROPEAN RESPIRATORY JOURNAL

Effect of Different Interferonα2 Preparations on IP10 and ET-1 Release from Human Lung Cells

(2012) Rekha Badiger et al.   PLoS One

Vardenafil in Pulmonary Arterial Hypertension

(2011) Zhi-Cheng Jing et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of Tipranavir/Ritonavir Combination on the Pharmacokinetics of Tadalafil in Healthy Volunteers

(2011) R. Garraffo et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension

(2011) Jürgen Venitz et al.   JOURNAL OF CLINICAL PHARMACOLOGY

HIV infection and pulmonary arterial hypertension

(2011) Stefania Cicalini et al.   Expert Review of Respiratory Medicine

Viral infection and pulmonary hypertension: is there an association?

(2011) Carlyne D Cool et al.   Expert Review of Respiratory Medicine

Mutual pharmacokinetic interactions between bosentan and lopinavir/ritonavir in healthy participants

(2010) Jasper Dingemanse et al.   ANTIVIRAL THERAPY

Pulmonary Hypertension Associated With HIV Infection

(2010) Sharilyn Almodovar et al.   CHEST

Human γ-Herpesviruses Epstein-Barr Virus and Human Herpesvirus-8 Are Not Detected in the Lungs of Patients With Severe Pulmonary Arterial Hypertension

(2010) Séverine Valmary et al.   CHEST

Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach

(2010) S. Cicalini et al.   CLINICAL MICROBIOLOGY AND INFECTION

Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C

(2010) Sonu Dhillon et al.   DIGESTIVE DISEASES AND SCIENCES

Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension

(2010) D. Montani et al.   EUROPEAN HEART JOURNAL

Iron deficiency is common in idiopathic pulmonary arterial hypertension

(2010) G. Ruiter et al.   EUROPEAN RESPIRATORY JOURNAL

Interaction involving tadalafil and CYP3A4 inhibition by ritonavir

(2010) Pierre Loulergue et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

(2009) David Montani et al.   ADVANCES IN THERAPY

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era

(2009) Bruno Degano et al.   AIDS

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects

(2009) V Sekar et al.   CLINICAL DRUG INVESTIGATION

Treatment and Outcome of Pulmonary Arterial Hypertension in HIVInfected Patients: A Review of the Literature

(2009) Stefania Cicalini et al.   CURRENT HIV RESEARCH

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Pulmonary Arterial Hypertension and HIV Infection

(2009) Bruno Degano et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era

(2008) Milos Opravil et al.   AIDS

Pulmonary arterial hypertension and HIV infection

(2008) Stefania Cicalini et al.   AIDS

Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers ofBMPR2Mutation

(2008) Benjamin Sztrymf et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pulmonary Vascular Disease in the Developing World

(2008) Ghazwan Butrous et al.   CIRCULATION

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Nazzareno Galiè et al.   CIRCULATION

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension

(2008) B. Degano et al.   EUROPEAN RESPIRATORY JOURNAL

Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study

(2008) N Reinsch et al.   HIV MEDICINE

HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism

(2008) I Petrache et al.   THORAX

Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era

(2007) Olivier Sitbon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE